2011
DOI: 10.1177/0194599811399866
|View full text |Cite
|
Sign up to set email alerts
|

Balloon Dilation of the Cartilaginous Eustachian Tube

Abstract: Dilation of the cartilaginous ET appeared to be beneficial and without significant adverse effects in the treatment of ET dilatory dysfunction. Larger controlled trials with long-term results are now justified and needed.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
93
0
1

Year Published

2012
2012
2019
2019

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 133 publications
(96 citation statements)
references
References 17 publications
2
93
0
1
Order By: Relevance
“…Nine prospective studies, 4,6,[8][9][10][11][12][13][14] describing 713 eustachian tube balloon dilations in 474 patients (aged 18-86 years), were identified. Follow-up duration ranged from 1.5 to 18 months.…”
Section: Resultsmentioning
confidence: 99%
See 4 more Smart Citations
“…Nine prospective studies, 4,6,[8][9][10][11][12][13][14] describing 713 eustachian tube balloon dilations in 474 patients (aged 18-86 years), were identified. Follow-up duration ranged from 1.5 to 18 months.…”
Section: Resultsmentioning
confidence: 99%
“…As a potential solution for this, eustachian tube balloon dilation (proposed as a treatment for chronic eustachian tube dysfunction) aims to ventilate and drain the middle ear by improving the physiological function of the eustachian tube. 6,10 The initial papers by Ockermann et al in 2010 5,6 and Poe et al in 2011 10,17 focused on establishing the safety of eustachian tube balloon dilation by performing both cadaveric and clinical studies. The cadaveric studies revealed no evidence of fractures to the cartilaginous or bony lumen, and no damage to the internal carotid artery.…”
Section: Discussionmentioning
confidence: 99%
See 3 more Smart Citations